| P50 | author | Albert Kapikian | Q4710611 |
| P2093 | author name string | Midthun K | |
| P2860 | cites work | Antigenic relationships among human rotaviruses as determined by outer capsid protein VP4 | Q33795720 |
| | Combined vaccination with live oral polio vaccine and the bovine rotavirus RIT 4237 strain | Q70159674 |
| | Protection Studies in Colostrum-Deprived Piglets of a Bovine Rotavirus Vaccine Candidate Using Human Rotavirus Strains for Challenge | Q70180815 |
| | Expression of a major bovine rotavirus neutralisation antigen (VP7c) in Escherichia coli | Q70191784 |
| | Use of bovine milk concentrate containing antibody to rotavirus to treat rotavirus gastroenteritis in infants | Q70345379 |
| | Fecal antibody responses to symptomatic and asymptomatic rotavirus infections | Q70579479 |
| | Influence of temperature and relative humidity on human rotavirus infection in Japan | Q71654505 |
| | A bovine rotavirus developed as a candidate vaccine for use in humans | Q72411319 |
| | Protection of infants against rotavirus diarrhoea by RIT 4237 attenuated bovine rotavirus strain vaccine | Q72578133 |
| | Chronic rotavirus infection in immunodeficiency | Q72853639 |
| | Viral gastroenteritis | Q72940993 |
| | Clinical trials of live oral rotavirus vaccines: the Finnish experience | Q72951305 |
| | Efficacy of Two Doses of RIT 4237 Bovine Rotavirus Vaccine for Prevention of Rotavirus Diarrhoea | Q56816816 |
| | Rhesus Rotavirus candidate vaccine. Clinical trial in children vaccinated between 2 and 5 months of age | Q56816817 |
| | Prevention of rotavirus infection by oral administration of cow colostrum containing antihumanrotavirus antibody | Q57114011 |
| | Gastroenteritis Due to Rotavirus in an Isolated Pacific Island Group: An Epidemic of 3,439 Cases | Q57115540 |
| | A Two-Year Study of Bacterial, Viral, and Parasitic Agents Associated with Diarrhea in Rural Bangladesh | Q57925806 |
| | Oral immunoglobulins for treatment of acute rotaviral gastroenteritis | Q61504639 |
| | Rotavirus as a cause of diarrheal morbidity and mortality in the United States | Q64129980 |
| | Oral administration of human rotavirus to volunteers: induction of illness and correlates of resistance | Q67258021 |
| | Clinical immunity after neonatal rotavirus infection. A prospective longitudinal study in young children | Q67297435 |
| | Field trial of rhesus rotavirus or human-rhesus rotavirus reassortant vaccine of VP7 serotype 3 or 1 specificity in infants. The Elmwood, Panorama, and Westfall Pediatric Groups | Q67492593 |
| | Protective efficacy against serotype 1 rotavirus diarrhea by live oral rhesus-human reassortant rotavirus vaccines with human rotavirus VP7 serotype 1 or 2 specificity | Q67503933 |
| | Expression of rotavirus VP7 antigens in fusions with bacterial proteins | Q68080513 |
| | Comparison of reactogenicity and antigenicity of M37 rotavirus vaccine and rhesus-rotavirus-based quadrivalent vaccine | Q68094488 |
| | A field study of the safety and efficacy of two candidate rotavirus vaccines in a Native American population | Q68198935 |
| | Immunogenicity and safety of rhesus-human rotavirus reassortant vaccines with serotype 1 or 2 VP7 specificity | Q68249373 |
| | Safety and Immunogenicity of Human Rotavirus Vaccine Strain M37 in Adults, Children, and Infants | Q68254459 |
| | Effect of breast-feeding on oral rhesus rotavirus vaccine seroconversion: a metaanalysis | Q68473417 |
| | Evaluation of WC3 rotavirus vaccine and correlates of protection in healthy infants | Q68484087 |
| | Prolonged efficacy of rhesus rotavirus vaccine in Swedish children | Q69334937 |
| | Simultaneous administration of rhesus rotavirus vaccine and oral poliovirus vaccine: immunogenicity and reactogenicity | Q69359097 |
| | Three-dimensional structure of rotavirus | Q69822358 |
| | Interference of oral poliovirus vaccine on RIT 4237 oral rotavirus vaccine | Q69823504 |
| | Seroconversion patterns to four human rotavirus serotypes in hospitalized infants with acute rotavirus gastroenteritis | Q69835765 |
| | Field trial of rhesus rotavirus vaccine in infants | Q69839488 |
| | Diverse serologic response to rotavirus infection of infants in a single epidemic | Q70120021 |
| | Immune response of infants and children to low-passage bovine rotavirus (strain WC3) | Q70131568 |
| | Evaluation of rhesus rotavirus vaccine (MMU 18006) in infants and young children | Q70138090 |
| | Response to RIT 4237 oral rotavirus vaccine in breast-fed and formula-fed infants | Q70148072 |
| | Preliminary evaluation of the efficacy of rhesus rotavirus vaccine strain MMU 18006 in young children | Q70148962 |
| | Safety and immunogenicity of live attenuated rhesus monkey rotavirus vaccine | Q70154380 |
| | Reassortant rotaviruses containing structural proteins vp3 and vp7 from different parents induce antibodies protective against each parental serotype | Q33927670 |
| | Clinical efficacy of the RIT 4237 live attenuated bovine rotavirus vaccine in infants vaccinated before a rotavirus epidemic | Q34193979 |
| | Protection from Rotavirus Reinfection: 2-Year Prospective Study | Q34497453 |
| | Global seasonality of rotavirus infections | Q34562653 |
| | Oral administration of human serum immunoglobulin in immunodeficient patients with viral gastroenteritis. A pharmacokinetic and functional analysis | Q34570330 |
| | An Update on the “Jennerian” and Modified “Jennerian” Approach to Vaccination of Infants and Young Children Against Rotavirus Diarrhea | Q35210846 |
| | Cell culture propagation of neonatal calf diarrhea (scours) virus. | Q35217248 |
| | Selection of cold-adapted mutants of human rotaviruses that exhibit various degrees of growth restriction in vitro | Q36637434 |
| | Identification of VP7 epitopes associated with protection against human rotavirus illness or shedding in volunteers | Q36656398 |
| | Recovery from chronic rotavirus infection in mice with severe combined immunodeficiency: virus clearance mediated by adoptive transfer of immune CD8+ T lymphocytes | Q36783022 |
| | The rhesus rotavirus outer capsid protein VP4 functions as a hemagglutinin and is antigenically conserved when expressed by a baculovirus recombinant. | Q36791884 |
| | Rotavirus-specific cytotoxic T lymphocytes passively protect against gastroenteritis in suckling mice | Q36796390 |
| | Immunization with baculovirus-expressed VP4 protein passively protects against simian and murine rotavirus challenge | Q36803819 |
| | Conservation of the fourth gene among rotaviruses recovered from asymptomatic newborn infants and its possible role in attenuation | Q36870349 |
| | Infection immunity of piglets to either VP3 or VP7 outer capsid protein confers resistance to challenge with a virulent rotavirus bearing the corresponding antigen | Q36875550 |
| | Sequence of the fourth gene of human rotaviruses recovered from asymptomatic or symptomatic infections. | Q36879244 |
| | Vaccinia virus recombinants expressing the SA11 rotavirus VP7 glycoprotein gene induce serotype-specific neutralizing antibodies | Q36886323 |
| | Reassortant rotaviruses as potential live rotavirus vaccine candidates | Q36899609 |
| | Protection against rotavirus-induced gastroenteritis in a murine model by passively acquired gastrointestinal but not circulating antibodies | Q36900226 |
| | Rotavirus gene structure and function | Q37055891 |
| | Isolation and characterization of two distinct human rotavirus strains with G6 specificity | Q37114071 |
| | Reactogenicity and immunogenicity of a high-titer rhesus rotavirus-based quadrivalent rotavirus vaccine | Q37133579 |
| | Prevalent patterns of serotype-specific seroconversion in Mexican children infected with rotavirus. | Q37141431 |
| | Development of neutralizing antibodies and group A common antibodies against natural infections with human rotavirus. | Q37152709 |
| | Reactions to and antigenicity of two human-rhesus rotavirus reassortant vaccine candidates of serotypes 1 and 2 in Venezuelan infants. | Q37169945 |
| | Single gene substitution rotavirus reassortants containing the major neutralization protein (VP7) of human rotavirus serotype 4. | Q37212147 |
| | Heterologous protection against rotavirus-induced disease in gnotobiotic piglets | Q37213543 |
| | Clinical studies of a quadrivalent rotavirus vaccine in Venezuelan infants | Q37228110 |
| | Rotavirus-associated diarrhea in rural Bangladesh: two-year study of incidence and serotype distribution | Q37239378 |
| | Pediatric viral gastroenteritis during eight years of study | Q37254420 |
| | Independent segregation of two antigenic specificities (VP3 and VP7) involved in neutralization of rotavirus infectivity | Q37558684 |
| | Molecular biology of rotaviruses | Q37895469 |
| | Molecular determinant of rotavirus neutralization and protection | Q38203578 |
| | Strategies for the development of a rotavirus vaccine against infantile diarrhea with an update on clinical trials of rotavirus vaccines. | Q38321647 |
| | Reovirus-like agent as a cause of nosocomial diarrhea in infants | Q38484410 |
| | Trial of an attenuated bovine rotavirus vaccine (RIT 4237) in Gambian infants | Q39044644 |
| | Importance of a new virus in acute sporadic enteritis in children | Q39315155 |
| | Asymptomatic endemic rotavirus infections in the newborn | Q39492190 |
| | Rotavirus: the major etiologic agent of severe infantile diarrhea may be controllable by a "Jennerian" approach to vaccination | Q39501137 |
| | Neonatal calf diarrhoea: identification of a reovirus-like (rotavirus) agent in faeces by immunofluorescence and immune electron microscopy | Q39961455 |
| | Human Reovirus-like Agent as the Major Pathogen Associated with “Winter” Gastroenteritis in Hospitalized Infants and Young Children | Q39981162 |
| | Human reovirus-like agent infection. Occurrence in adult contacts of pediatric patients with gastroenteritis | Q40079834 |
| | A study of the prevalence of rotavirus infection in children with gastroenteritis admitted to an infectious diseases hospital | Q40135924 |
| | VP4 typing of bovine and porcine group A rotaviruses by PCR. | Q40178826 |
| | Hemagglutination by a human rotavirus isolate as evidence for transmission of animal rotaviruses to humans | Q40185948 |
| | Prevalence of antibody to the Norwalk agent by a newly developed immune adherence hemagglutination assay | Q40198967 |
| | Rotaviral Immunity in Gnotobiotic Calves: Heterologous Resistance to Human Virus Induced by Bovine Virus | Q40200919 |
| | Interspecies Transmission of Rotaviruses Studied from the Perspective of Genogroup | Q40489158 |
| | Rotavirus antigens | Q40683372 |
| | Rotavirus vaccine development for the prevention of severe diarrhea in infants and young children | Q40700334 |
| | Evaluation of the antigenicity and reactogenicity of varying formulations of the rhesus rotavirus-based quadrivalent and the M37 rotavirus vaccine candidates | Q40702488 |
| | Evaluation of the M37 human rotavirus vaccine in 2- to 6-month-old infants. | Q40742565 |
| | Immune protection of infants against rotavirus gastroenteritis by a serotype 1 reassortant of bovine rotavirus WC3. | Q40761869 |
| | An efficacy trial of the rhesus rotavirus vaccine in Maryland. The Clinical Study Group | Q40762520 |
| | Human-rhesus reassortant rotavirus vaccines: safety and immunogenicity in adults, infants, and children | Q40781870 |
| | Protective effect of WC3 vaccine against rotavirus diarrhea in infants during a predominantly serotype 1 rotavirus season | Q40783935 |
| | Candidate rotavirus vaccine (rhesus rotavirus strain) in children: an evaluation | Q40793640 |
| | Immunogenicity and safety of a low passage level bovine rotavirus candidate vaccine RIT 4256 in human adults and young infants | Q40796895 |
| | Immunogenicity and reactogenicity of lowered doses of rhesus rotavirus vaccine strain MMU 18006 in young children | Q40799296 |
| | Reactogenicity and antigenicity of the rhesus rotavirus vaccine in Venezuelan children. | Q40800035 |
| | A comparative trial of rhesus monkey (RRV-1) and bovine (RIT 4237) oral rotavirus vaccines in young children | Q40808747 |
| | Safety, infectivity, transmissibility and immunogenicity of rhesus rotavirus vaccine (MMU 18006) in infants | Q40812933 |
| | Protection of Peruvian children against rotavirus diarrhea of specific serotypes by one, two, or three doses of the RIT 4237 attenuated bovine rotavirus vaccine | Q41241678 |
| | Cold-adaptation of human rotavirus | Q41327546 |
| | Immunogenicity and safety of live oral attenuated bovine rotavirus vaccine strain RIT 4237 in adults and young children | Q41440921 |
| | Systemic and mucosal immune responses to rhesus rotavirus vaccine MMU 18006. | Q41902985 |
| | Neonatal rotavirus vaccination with RIT 4237 bovine rotavirus vaccine: a preliminary report | Q42143436 |
| | Rotavirus infection of the oropharynx and respiratory tract in young children | Q43454021 |
| | Dose-response study of RIT 4237 oral rotavirus vaccine in breast-fed and formula-fed infants | Q43482843 |
| | Evaluation of the efficacy of a low-passage bovine rotavirus (strain WC3) vaccine in children in Central Africa | Q43492399 |
| | Prevention of Human Rotavirus-Induced Diarrhea in Gnotobiotic Piglets using Bovine Antibody | Q43555515 |
| | Vaccinia—rotavirus VP7 recombinants protect mice against rotavirus-induced diarrhoea | Q43601287 |
| | Seroepidemiologic Evaluation of Antibodies to Rotavirus as Correlates of the Risk of Clinically Significant Rotavirus Diarrhea in Rural Bangladesh | Q43744091 |
| | Failure of live, attenuated oral rotavirus vaccine | Q43753182 |
| | Immunogenicity of Tetravalent Rhesus Rotavirus Vaccine Administered With Buffer and Oral Polio Vaccine | Q43834301 |
| | Immunogenicity and reactogenicity of rhesus rotavirus vaccine given in combination with oral or inactivated poliovirus vaccines and diphtheria-tetanus-pertussis vaccine | Q43917518 |
| | Group- and type-specific serologic response in infants and children with primary rotavirus infections and gastroenteritis caused by a strain of known serotype | Q43921519 |
| | Effects of antibody to rotavirus on protection of adults challenged with a human rotavirus | Q44083567 |
| | Detection of rotavirus antigen in tracheal aspirates of infants and children with pneumonia | Q44162718 |
| | Evaluation of RIT 4237 bovine rotavirus vaccine in newborn infants: correlation of vaccine efficacy to season of birth in relation to rotavirus epidemic period | Q44284848 |
| | Synthesis of the surface glycoprotein of rotavirus SA11 in the aroA strain of Salmonella typhimurium SL3261. | Q44406843 |
| | Rotavirus infection in lambs: studies on passive protection | Q44551250 |
| | Acquisition of Serum Antibody to Norwalk Virus and Rotavirus and Relation to Diarrhea in a Longitudinal Study of Young Children in Rural Bangladesh | Q45800527 |
| | Development of a diploid cell line from fetal rhesus monkey lung for virus vaccine production | Q45819880 |
| | Protection against severe rotavirus diarrhoea by rhesus rotavirus vaccine in Venezuelan infants | Q46129217 |
| | VP4 protein of porcine rotavirus strain OSU expressed by a baculovirus recombinant induces neutralizing antibodies | Q46156185 |
| | A randomised trial of oral gammaglobulin in low-birth-weight infants infected with rotavirus | Q47267339 |
| | Distribution of fasting serum insulin measured by enzyme immunoassay in an unselected population of 4,032 individuals. Reference values according to age and sex. D.E.S.I.R. Study Group. Données Epidémiologiques sur le Syndrome d'Insulino-Résistance. | Q50982024 |
| | Passive immunisation of children with bovine colostrum containing antibodies to human rotavirus. | Q54105146 |
| | Prospective study of diarrheal diseases in Venezuelan children to evaluate the efficacy of rhesus rotavirus vaccine. | Q54329594 |
| | Protective effect of naturally acquired homotypic and heterotypic rotavirus antibodies. | Q54423952 |
| | Synthesis in Escherichia coli and immunological characterization of a polypeptide containing the cleavage sites associated with trypsin enhancement of rotavirus SA11 infectivity. | Q54767094 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | rotavirus vaccine | Q4411598 |
| P304 | page(s) | 423-434 | |
| P577 | publication date | 1996-07-01 | |
| P1433 | published in | Clinical Microbiology Reviews | Q5133777 |
| P1476 | title | Rotavirus vaccines: an overview | |
| P478 | volume | 9 | |